Patenting at the UM Rene Vleugels Office of knowledge transfer
Patenting No university policy Decentral approach Ownership for third parties Royalty payments?
Patents
Patent Instructions UM Ownership Procedure Obligations of the UM inventor Financing of patents Distribution of revenues
Patent Portfolio Uitvinder(-s)Titel (afgekort)License C. BruggemanAzetidinone derivaten - P.C. DagnelieAdenosine trifostfaat in relatie tot kanker- G. RietjesSchoenadapter - M. DeutzTryptophan Concentration- A. BastNovel flavenoidenSTW P. FrederikVitrobotFEI G. HaenenReductie toxiciteit van flavonoidenSTW J. LuikenRegulator insuline-opname van de cel- F. JongsmaDroge Cornea topograafStart-up G. HagemanVoedingscomponenten als remmer van PARP-1STW F. JongsmaRaman spectroscopyRE R’dam M. EngelenVoedingssupplement GlutamaatRoche B.Schutte K18 fragments and uses thereofMubio BV W. HermensPEIA applications,,TNO J. Plat ABC-G8 gen,,- M.Pelzersbrain injury assay,,- J. Maessen epicardial pace locator,,- C. VermeerSerum marker diagnostiek van atheroscleroseVitak BV
Exploitation (1) Licensing of patent to companies 1.Short description: flyer 2.Selection of companies 3.Identification of Contactpersons 4.Patent Assignment Agreement
Patent Assignment Agreement Exclusivity vs. non-exclusivity Specific applications Exclusive status as CRO and Consultancy Prevention of non-applicability License Period Up-front payment + Royalty payments Milestone payment related to R&D development
Exploitation(2) Basis for a start-up company Entrepreneurship Business Idea Training Business plan